Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Corey

Showing results (331-340 of 551) with videos related to

Pageof 56
Sort By:
Journal of Hepatology|June 1, 2005
Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: a two-year studyRobert G Gish, Huy Trinh, Nancy Leung, et al.
JAMA|December 21, 2016
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical TrialAnna Wald, Burkhard Timmler, Amalia Magaret, et al.
The Journal of Infectious Diseases|February 10, 2017
Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV PneumoniaMichael Boeckh, Terry Stevens-Ayers, Giovanna Travi, et al.
Frontiers in Immunology|June 21, 2024
SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responsesTim R Mosmann, Jonathan A Rebhahn, Stephen C De Rosa, et al.
Plos One|September 7, 2012
MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral loadHolly Janes, Nicole Frahm, Allan DeCamp, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Identification of potent HSV antivirals using 3D bioprinted human skin equivalentsS Tori Ellison, Ian Hayman, Kristy Derr, et al.
Nature Communications|October 16, 2025
Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalentsS Tori Ellison, Ian Hayman, Kristy Derr, et al.
Plos One|January 22, 2009
Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in UgandaChristine Johnston, Jackson Orem, Fred Okuku, et al.
Plos Pathogens|July 3, 2013
HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1Tomer Hertz, Hasan Ahmed, David P Friedrich, et al.
JAMA|July 24, 2008
Cytomegalovirus reactivation in critically ill immunocompetent patientsAjit P Limaye, Katharine A Kirby, Gordon D Rubenfeld, et al.
Pageof 56

Showing results (331-340 of 551) with videos related to

Sort By:
Pageof 56
Journal of Hepatology|June 1, 2005
Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: a two-year studyRobert G Gish, Huy Trinh, Nancy Leung, et al.
JAMA|December 21, 2016
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical TrialAnna Wald, Burkhard Timmler, Amalia Magaret, et al.
The Journal of Infectious Diseases|February 10, 2017
Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV PneumoniaMichael Boeckh, Terry Stevens-Ayers, Giovanna Travi, et al.
Frontiers in Immunology|June 21, 2024
SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responsesTim R Mosmann, Jonathan A Rebhahn, Stephen C De Rosa, et al.
Plos One|September 7, 2012
MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral loadHolly Janes, Nicole Frahm, Allan DeCamp, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Identification of potent HSV antivirals using 3D bioprinted human skin equivalentsS Tori Ellison, Ian Hayman, Kristy Derr, et al.
Nature Communications|October 16, 2025
Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalentsS Tori Ellison, Ian Hayman, Kristy Derr, et al.
Plos One|January 22, 2009
Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in UgandaChristine Johnston, Jackson Orem, Fred Okuku, et al.
Plos Pathogens|July 3, 2013
HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1Tomer Hertz, Hasan Ahmed, David P Friedrich, et al.
JAMA|July 24, 2008
Cytomegalovirus reactivation in critically ill immunocompetent patientsAjit P Limaye, Katharine A Kirby, Gordon D Rubenfeld, et al.
Pageof 56